U.S. flag

An official website of the United States government

NM_001114753.3(ENG):c.2T>G (p.Met1Arg) AND Telangiectasia, hereditary hemorrhagic, type 1

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Mar 15, 2024
Review status:
3 stars out of maximum of 4 stars
reviewed by expert panel
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003989113.1

Allele description [Variation Report for NM_001114753.3(ENG):c.2T>G (p.Met1Arg)]

NM_001114753.3(ENG):c.2T>G (p.Met1Arg)

Gene:
ENG:endoglin [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
9q34.11
Genomic location:
Preferred name:
NM_001114753.3(ENG):c.2T>G (p.Met1Arg)
Other names:
NM_001114753.3(ENG):c.2T>G; p.Met1Arg
HGVS:
  • NC_000009.12:g.127854354A>C
  • NG_009551.1:g.5415T>G
  • NM_000118.4:c.2T>G
  • NM_001114753.3:c.2T>GMANE SELECT
  • NM_001406715.1:c.2T>G
  • NP_000109.1:p.Met1Arg
  • NP_000109.1:p.Met1Arg
  • NP_001108225.1:p.Met1Arg
  • NP_001108225.1:p.Met1Arg
  • NP_001393644.1:p.Met1Arg
  • LRG_589t1:c.2T>G
  • LRG_589t2:c.2T>G
  • LRG_589:g.5415T>G
  • LRG_589p1:p.Met1Arg
  • LRG_589p2:p.Met1Arg
  • NC_000009.11:g.130616633A>C
  • NM_000118.2:c.2T>G
  • NM_000118.3:c.2T>G
  • NM_001114753.2:c.2T>G
Protein change:
M1R
Links:
dbSNP: rs267606783
NCBI 1000 Genomes Browser:
rs267606783
Molecular consequence:
  • NM_001114753.3:c.2T>G - initiator_codon_variant - [Sequence Ontology: SO:0001582]
  • NM_000118.4:c.2T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001114753.3:c.2T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406715.1:c.2T>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Telangiectasia, hereditary hemorrhagic, type 1 (HHT1)
Synonyms:
Osler Weber Rendu syndrome type 1
Identifiers:
MONDO: MONDO:0008535; MedGen: C4551861; Orphanet: 774; OMIM: 187300

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004805878ClinGen Hereditary Hemorrhagic Telangiectasia Variant Curation Expert Panel, ClinGen
reviewed by expert panel

(ClinGen HHT ACMG Specifications ENG V1.1.0)
Pathogenic
(Mar 15, 2024)
germlinecuration

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedcuration

Details of each submission

From ClinGen Hereditary Hemorrhagic Telangiectasia Variant Curation Expert Panel, ClinGen, SCV004805878.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcurationnot provided

Description

The NM_001114753.3: c.2T>G variant in ENG may cause a truncated or absent protein by altering the start codon of the coding sequence and is predicted to lead to the omission of a critical region of the protein (PVS1_Strong). This variant is absent from gnomAD v2.1.1 (PM2_Supporting). This variant has been reported in >4 probands with a phenotype consistent with HHT (PS4; PMID:12920067, 32300199, 15024723, ClinVar, Internal lab contributors). At least one patient's phenotype meets Curacao Criteria for HHT, and sequencing and large deletion/duplication analysis was performed for ENG and ACVRL1, which is highly specific for HHT (PP4_Moderate; Internal lab contributors). Four different missense variants, c.3G>A, c.1A>T, c.2T>C, c.1A>G, in the same codon have been classified as pathogenic/likely pathogenic for autosomal dominant hereditary hemorrhagic telangiectasia by the ClinGen Hereditary Hemorrhagic Telangiectasia Variant Curation Expert Panel (PM5_Strong). In summary, this variant meets the criteria to be classified as pathogenic for autosomal dominant hereditary hemorrhagic telangiectasia based on the ACMG/AMP criteria applied, as specified by the ClinGen Hereditary Hemorrhagic Telangiectasia Variant Curation Expert Panel: PM2_Supporting, PVS1_Strong, PS4, PP4_Moderate, PM5_Strong (specification version 1.0.0; 1/4/2024).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 13, 2024